Bvf Inc/il

Filing Details

13F-HR2025-03-31
Report Date
2025-03-31
Filing Date
2025-05-15
Total Holdings
51
Total Value
2453567172
Accession Number
0000921895-25-001528
Form Type
13F-HR
Manager Name
Bvf Inc/il
Data Enrichment
96% identified
49 identified2 unidentified

Holdings

51 positions
Manager:
Search and click to pin securities to the top
Page 3 of 3
Forte Biosciences, Inc.
Shares:
594282(+0.0%)
Value:
$4.6B(-65.8%)
Allakos Inc.
Shares:
16552417(+0.0%)
Value:
$3.8B(-81.2%)
CytomX Therapeutics, Inc.
Shares:
5228461(+0.0%)
Value:
$3.3B(-38.3%)
TENAX THERAPEUTICS, INC.
Shares:
339549(+0.0%)
Value:
$2.2B(+5.8%)
Inventiva S.A.
Shares:
686040(+0.0%)
Value:
$2.1B(+39.5%)
GLYCOMIMETICS INC
Shares:
9544262(+0.0%)
Value:
$2.0B(-15.7%)
SAB Biotherapeutics, Inc.
Shares:
917826(+0.0%)
Value:
$1.2B(-64.7%)
NewAmsterdam Pharma Co N.V.
Shares:
59065
Value:
$1.2B
Ovid Therapeutics Inc.
Shares:
3853818(+0.0%)
Value:
$1.2B(-66.6%)
29286M113
Shares:
945402(+0.0%)
Value:
$605.1M(-24.7%)
H57830137
Shares:
143676(+0.0%)
Value:
$221.3M(-27.0%)